Sort
82,697 grants matching “vaccine development”
Administrative Core
$936,879David H Walker · University Of Texas Med Br Galveston · U54 · FY2010 · AI
Maximizing germinal centers and somatic hypermutation to HIV Env immunogens
$936,822Shane P Crotty · La Jolla Institute For Immunology · R01 · FY2016 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$936,750Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Targeting the Epigenome for Lung Cancer Therapy
$936,250David Schrump · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Project 3: Nucleoside-modified mRNA-LNP vaccine platform
$936,112Barton F Haynes · Duke University · P01 · FY2023 · AI
Mechanisms of human papillomavirus entry
$935,762Daniel Dimaio · Yale University · R35 · FY2024 · CA
Chicago Community-Acquired Pneumonia Consortium
$935,655Richard G Wunderink · Northwestern University At Chicago · U18 · FY2010 · IP
Preclinical development of a novel antibacterial for Clostridium difficile diseas
$935,484George E Wright · Glsynthesis, Inc. · R44 · FY2011 · AI
CMV Subunit Vaccine in Young Women at Risk
$935,465Robert Floyd Pass · University Of Alabama At Birmingham · U01 · FY2007 · AI
Cytolytic antibodies:Bridging the gap between the innate and adaptive immune resp
$935,323Galit Alter · Massachusetts General Hospital · R01 · FY2010 · AI
VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE
$935,147Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2009 · RR
Consensus Gene-Based Immunogens in Rhesus Monkeys
$935,034Norman L Letvin · Duke University · P01 · FY2007 · AI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION
$935,011Kathy L Rowlen · Indevr, Inc. · R44 · FY2016 · AI
Adjuvant Comparison and Characterization of Peanut Antigen
$934,999Herman Staats · Duke University · N01 · FY2025 · AI
Developmental Core- Pilot Projects, Full Projects, Biostat Core and Outreach Prog
$934,996Raymond Nelson Dubois · University Of Tx Md Anderson Can Ctr · U54 · FY2010 · CA
Studying factors controlling cancer progression and immune recognition in mouse models
$934,920Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2023 · CA
SEQUENCE AND POLYMORPHISM OF RHESUS MACAQUE MHC
$934,901Daniel E Geraghty · Fred Hutchinson Cancer Research Center · R24 · FY2006 · RR
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$934,853Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2025 · AI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding
$934,848Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2020 · AI
BIOLOGY OF ALIMENTARY EPITHELIA IN HEALTH AND DISEASE
$934,760Children'S Hospital Boston · P30 · FY2001 · DK
BIOLOGY OF ALIMENTARY EPITHELIA IN HEALTH AND DISEASE
$934,759Children'S Hospital Boston · P30 · FY2003 · DK
BIOLOGY OF ALIMENTARY EPITHELIA IN HEALTH AND DISEASE
$934,759Children'S Hospital Boston · P30 · FY2002 · DK
HANTAVIRUS ECOLOGY AND DISEASE IN CHILE AND PANAMA
$934,697Gregory James Mertz · University Of New Mexico · U19 · FY2006 · AI
Integrating genomics and the protein interactome for HPV+ head and neck cancer therapy
$934,594Jennifer R Grandis · University Of California, San Francisco · R35 · FY2019 · CA
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for Natural History Challenge Studies for Influenza
$934,569Emmanuel Walter · Duke University · N01 · FY2019 · AI